Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Mark T. Muller"'
Autor:
Yunke Wang, Samantha Rakela, Jeremy W. Chambers, Zi-Chun Hua, Mark T. Muller, John L. Nitiss, Yuk-Ching Tse-Dinh, Fenfei Leng
Publikováno v:
ACS Omega, Vol 4, Iss 19, Pp 18413-18422 (2019)
Externí odkaz:
https://doaj.org/article/160a7ee6f656476ca20d7340cea6570e
Autor:
Concetta Cuozzo, Antonio Porcellini, Tiziana Angrisano, Annalisa Morano, Bongyong Lee, Alba Di Pardo, Samantha Messina, Rodolfo Iuliano, Alfredo Fusco, Maria R Santillo, Mark T Muller, Lorenzo Chiariotti, Max E Gottesman, Enrico V Avvedimento
Publikováno v:
PLoS Genetics, Vol 13, Iss 2, p e1006605 (2017)
[This corrects the article DOI: 10.1371/journal.pgen.0030110.].
Externí odkaz:
https://doaj.org/article/b7a09eb129ca4173bd0c40a46c7a9979
Autor:
Concetta Cuozzo, Antonio Porcellini, Tiziana Angrisano, Annalisa Morano, Bongyong Lee, Alba Di Pardo, Samantha Messina, Rodolfo Iuliano, Alfredo Fusco, Maria R Santillo, Mark T Muller, Lorenzo Chiariotti, Max E Gottesman, Enrico V Avvedimento
Publikováno v:
PLoS Genetics, Vol 3, Iss 7, p e110 (2007)
To explore the link between DNA damage and gene silencing, we induced a DNA double-strand break in the genome of Hela or mouse embryonic stem (ES) cells using I-SceI restriction endonuclease. The I-SceI site lies within one copy of two inactivated ta
Externí odkaz:
https://doaj.org/article/82d2ffe003bf4363ad319a00c5eac89e
Publikováno v:
Oncotarget
// Brittany Allen 1 , Antonio Pezone 2 , Antonio Porcellini 3 , Mark T. Muller 4 and Michal M. Masternak 1, 5 1 College of Medicine, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, USA 2 Dipartimento di Medicina Mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfc99a1efcb68ef26ae70c207279115f
https://doi.org/10.18632/oncotarget.16122
https://doi.org/10.18632/oncotarget.16122
Autor:
Qi Tony Zhou, Mei-Ling Han, Mark T. Muller, Jian Li, Tony Velkov, Elena K. Schneider, Yohei Doi, Mohammad Abul Kalam Azad, Mark Baker, Johnny X. Huang, Mark E. Cooper, Jiping Wang, Phillip J. Bergen
Publikováno v:
ACS Infectious Diseases. 2:478-488
Novel combination therapies are desperately needed for combating lung infections caused by bacterial "superbugs". This study aimed to investigate the synergistic antibacterial activity of polymyxin B in combination with the cystic fibrosis (CF) drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc350d7c3dc62621ad5cc75c4822d387
https://doi.org/10.1021/acsinfecdis.6b00035
https://doi.org/10.1021/acsinfecdis.6b00035
Autor:
Rodolfo Iuliano, Tiziana Angrisano, Bongyong Lee, Alfredo Fusco, Alba Di Pardo, Annalisa Morano, Antonio Porcellini, Enrico V. Avvedimento, Lorenzo Chiariotti, Mark T. Muller, Concetta Cuozzo, Samantha Messina, Maria R. Santillo, Max E. Gottesman
Publikováno v:
PLoS Genetics, Vol 13, Iss 2, p e1006605 (2017)
[This corrects the article DOI: 10.1371/journal.pgen.0030110.].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f62c063e952ad205bf37d1241fa8b8db
http://europepmc.org/articles/PMC5302286?pdf=render
http://europepmc.org/articles/PMC5302286?pdf=render
Autor:
Mark T. Muller, Gennaro Ilardi, Chiara Luise, Spiros Linardopoulos, Roberto Monaco, Angela Celetti, Francesco Merolla, Simona Paladino, Federica Zito-Marino, Gaetano Rocco, Francesco Morra, Roberta Visconti, Roberto Pacelli, Aniello Cerrato, Gianluca Guggino, Daniela Sarnataro, Renato Franco, Guglielmo Monaco, Stefania Staibano
Publikováno v:
International Journal of Cancer. 136:2146-2157
Non-small cell lung cancer (NSCLC) is the main cause of cancer-related death worldwide and new therapeutic strategies are urgently needed. In this study, we have characterized a panel of NSC lung cancer cell lines for the expression of coiled-coil-do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64a16ff614297d7aa6926c93000f0798
https://doi.org/10.1002/ijc.29263
https://doi.org/10.1002/ijc.29263
Autor:
Kate J. Akerman, Vidusha Cyril, Alexander M. Fagenson, Orde Q. Munro, Michael Taylor, Mark T. Muller, Matthew P. Akerman
Publikováno v:
Journal of the American Chemical Society
Topoisomerase IB (Top1) is a key eukaryotic nuclear enzyme that regulates the topology of DNA during replication and gene transcription. Anticancer drugs that block Top1 are either well-characterized interfacial poisons or lesser-known catalytic inhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbc1cf27ecee6b4fe97f7d0e6c985de2
https://doi.org/10.1021/ja412350f
https://doi.org/10.1021/ja412350f
Publikováno v:
ChemMedChem. 9:560-565
DNA hypomethylating drugs that act on DNA methyltransferase (DNMT) isoforms are promising anticancer agents. By using a well-characterized live-cell system to measure DNA methylation revisions (imprints), we characterize olsalazine, an approved anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d34f0d93fe1ca42932b71efeb04de6e
https://doi.org/10.1002/cmdc.201300555
https://doi.org/10.1002/cmdc.201300555
Autor:
Giovanni Scala, Giusi Russo, Enrico V. Avvedimento, Antonio Pezone, Lorenzo Chiariotti, Candida Zuchegna, Max E. Gottesman, Ermanno Florio, Rosaria Landi, Mark T. Muller, Alfonso Tramontano, Antonella Romano, Antonio Porcellini
Publikováno v:
Scientific Data
Genome-wide methylation analysis is limited by its low coverage and the inability to detect single variants below 10%. Quantitative analysis provides accurate information on the extent of methylation of single CpG dinucleotide, but it does not measur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187875c0036bd9b7f41b0be7a7d8a399
https://pubmed.ncbi.nlm.nih.gov/28398335
https://pubmed.ncbi.nlm.nih.gov/28398335